Estrogen's and progesterone's impact on gene expression in the mouse lacrimal gland

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 1, 2006, Pages 158-168

  Suzuki, Tomo ^a,b   Schirra, Frank ^a,b   Richards, Stephen M ^a,b   Treister, Nathaniel S ^a,c   Lombardi, Michael J ^d   Rowley, Patricia ^d   Jensen, Roderick V ^d   Sullivan, David A ^a,b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^d UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; PROGESTERONE; EYE PROTEIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CATALYSIS; CELL COMMUNICATION; CELL GROWTH; CONTROLLED STUDY; DNA MICROARRAY; DRUG MECHANISM; FEMALE; GENE ACTIVITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HORMONE ACTION; IMMUNE RESPONSE; LACRIMAL GLAND; MOUSE; NONHUMAN; NUCLEIC ACID METABOLISM; NUCLEOTIDE SEQUENCE; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN METABOLISM; PROTEIN SYNTHESIS REGULATION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; DRUG COMBINATION; DRUG EFFECT; GENETICS; LACRIMAL APPARATUS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; DRUG COMBINATIONS; ESTRADIOL; EYE PROTEINS; FEMALE; GENE EXPRESSION REGULATION; LACRIMAL APPARATUS; MICE; MICE, INBRED BALB C; OVARIECTOMY; PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 32244449499     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-1003     Document Type: Article

References (51)

1. Gabe M. Conditionnement hormonal de la morphologie des glandes sus-parotidiennes chez le Rat albinos. Compt Rend Seanc Soc Biol. 1955;149:223-225.
2. Baquiche M. Le dimorphisme sexuel de la glande de Loewenthal chez le rat albinos. Acta Anat. 1959;36:247-280.
3. Krawczuk-Hermanowiczowa O. Effect of sex hormones on the lacrimal gland. III. Effects of testosterone and oestradiol and of both these hormones jointly on the morphological appearance of the lacrimal gland in castrated rats [in Polish]. Klin Oczna. 1983;85:337-339.
4. Azzarolo AM, Eihausen H, Schechter J. Estrogen prevention of lacrimal gland cell death and lymphocytic infiltration. Exp Eye Res. 2003;77:347-354.
5. Mircheff AK. Understanding the causes of lacrimal insufficiency: implications for treatment and prevention of dry eye syndrome. Research to Prevent Blindness Science Writers Seminar. New York: Research to Prevent Blindness; 1993:51-54.
6. Lubkin V, Kramer P, Nash R, Bennett G. Evaluation of safety and efficacy of topical 17β-estradiol, 0.1% and 0.25%, in postmenopausal dry eye syndrome. Abstracts of the Second International Conference on the Lacrimal Gland, Tear Film and Dry Eye Syndromes: Basic Science and Clinical Relevance. Bermuda; 1996:160.
7. Krawczuk-Hermanowiczowa O. Effects of sexual glands on the lacrimal gland. II. Changes in rat lacrimal glands after castration. Klin Oczna. 1983;85:15-17.
8. Krasso I. Die behandlung der erkrankungen des vorderen bulbusabschnittes mit buckys grenzstrahlen. Ztschr f Augenh. 1930;71:1-11.
9. Lauria A, Porcelli F. Leucine aminopeptidase (LAP) activity and sexual dimorphism in rat exorbital gland. Basic Appl Histochem. 1979;23:171-177.
10. Wenderlein M, Mattes S. The "dry eye" phenomenon and ovarian function. Study of 700 women pre- and postmenopausal. Zentralbl Gynakol. 1996;118:643-649.
11. Guaschino S, Grimaldi E, Sartore A, et al. Visual function in menopause: the role of hormone replacement therapy. Menopause. 2003;10:53-57.
12. Cavallero C. The influence of various steroids on the Lowenthal lachrymal glands of the rat. Acta Endocrinol Suppl (Copenh). 1960;51:861.
13. Affinito P, Di Spiezio Sardo A, Di Carlo C, et al. Effects of hormone replacement therapy on ocular function in postmenopause. Menopause. 2003;10:482-487.
14. Kuscu NK, Toprak AB, Vatansever S, et al. Tear function changes of postmenopausal women in response to hormone replacement therapy. Maturitas. 2003;44:63-68.
15. Prijot E, Bazin L, Destexhe B. Essai de traitment hormonal de la keratocon-jonctivite seche. Bull Soc Belge Ophtalmol. 1972;162:795-800.
16. Sullivan DA, Bloch KJ, Allansmith MR. Hormonal influence on the secretory immune system of the eye: androgen regulation of secretory component levels in rat tears. J Immunol. 1984;132:1130-1135.
17. Winderickx J, Vercaeren I, Verhoeven G, Heyns W. Androgen-dependent expression of cystatin-related protein (CRP) in the exorbital lacrimal gland of the rat. J Steroid Biochem Molec Biol. 1994;48:165-170.
18. Vanaken H, Claessens F, Vercaeren I, Heyns W, Peeters B, Rombauts W. Androgenic induction of cystatin-related protein and the C3 component of prostatic binding protein in primary cultures from the rat lacrimal gland. Mol Cell Endocrinol. 1996;121:197-205.
19. Sullivan DA, Kelleher RS, Vaerman JP, Hann LE. Androgen regulation of secretory component synthesis by lacrimal gland acinar cells in vitro. J Immunol. 1990;145:4238-4244.
20. Laine M, Tenovuo J. Effect on peroxidase activity and specific binding of the hormone 17β-estradiol and rat salivary glands. Arch Oral Biol. 1983;8:847-852.
21. Pelit A, Bagis T, Kayaselcuk F, Dursun D, Akova Y, Aydin P. Tear function tests and conjunctival impression cytology before and after hormone replacement therapy in postmenopausal women. Eur J Ophthalmol. 2003;13:337-342.
22. Sato EH, Sullivan DA. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjögren's syndrome. Invest Ophthalmol Vis Sci. 1994;35:2632-2642.
23. Verbeck B. Augenbefunde und stoffwechselverhalten bei einnahme von ovulationshemmern. Klin Mbl Augenheilk. 1973;162:612-621.
24. Ranganathan V, De PK. Androgens and estrogens markedly inhibit expression of a 20-kDa major protein in hamster exorbital lacrimal gland. Biochem Biophys Res Commun. 1995;208:412-417.
25. Richards SM, Jensen RV, Liu M, et al. Influence of sex on gene expression in the mouse lacrimal gland. Exp Eye Res. In press.
26. Ashburner M, Ball CA, Blake JA, et al. Gene Ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25-29.
27. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR. MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol. 4;2003 R7 (http:// genomebiology.com/2003/4/1/R7).
28. National Center for BioTechnology. Information, http://www.ncbi.nlm.nih. gov/, and European Molecular Biology Laboratory Bioinformatic Harvester, http://harvester.embl.de/.
29. Davoren JB, Hsueh AJ. Insulin enhances FSH-stimulated steroidogenesis by cultured rat granulosa cells. Mol Cell Endocrinol. 1984;35:97-105.
30. Wong H, Schotz MC. The lipase gene family. J Lipid Res. 2002;43:993-999.
31. Pujuguet P, Simian M, Liaw J, Timpl R, Werb Z, Bissell MJ. Nidogen-1 regulates laminin-1-dependent mammary-specific gene expression. J Cell Sci. 2000;113:849-858.
32. Wright GJ, Cherwinski H, Foster-Cuevas M, et al. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol. 2003;171:3034-3046.
33. Alexander WS, Hilton DJ. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol. 2004;22:503-529.
34. Zanin-Zhorov A, Tal G, Shivtiel S, et al. Heat shock protein 60 activates cytokine-associated negative regulator suppressor of cytokine signaling 3 in T cells: effects on signaling, chemotaxis, and inflammation. J Immunol. 2005;175:276-285.
35. Orabona C, Belladonna ML, Vacca C, et al. Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. J Immunol. 2005;174:6582-6586.
36. Yoshimura A, Nishinakamura H, Matsumura Y, Hanada T. Negative regulation of cytokine signaling and immune responses by SOCS proteins. Arthritis Res Ther. 2005;7:100-110.
37. Ishimaru N, Saegusa K, Yanagi K, Haneji N, Saito I, Hayashi Y. Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through fas-mediated apoptosis. Am J Pathol. 1999;155:173-181.
38. Ochs HD, Ziegler SF, Torgerson TR. FOXP3 acts as a rheostat of the immune response. Immunol Rev. 2005;203:156-164.
39. Huan J, Culbertson N, Spencer L, et al. Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res. 2005;81:45-52.
40. Offner H. Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis. J Neurosci Res. 2004;78:603-624.
41. Polanczyk MJ, Carson BD, Subramanian S, et al. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol. 2004;173:2227-2230.
42. De Vita S, Damato R, De Marchi G, Sacco S, Ferraccioli G. True primary Sjogren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis. Isr Med Assoc J. 2002;4:1101-1105.
43. Toussirot E, Le Huede G, Mougin C, Balblanc JC, Bettinger D, Wendling D. Presence of hepatitis C virus RNA in the salivary glands of patients with Sjogren's syndrome and hepatitis C virus infection. J Rheumatol. 2002;29:2382-2385.
44. Siagris D, Pharmakakis N, Christofidou M, et al. Keratoconjunctivitis sicca and chronic HCV infection. Infection. 2002;30:229-233.
45. Carlsten H, Tarkowski A, Holmdahl R, Nilsson LA. Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin exp Immunol. 1990;80:467-473.
46. Ahmed SA, Aufdemorte TB, Chen JR, Montoya AI, Olive D, Talal N. Estrogen induces the development of autoantibodies and promotes salivary gland lymphoid infiltrates in normal mice. J Autoimmunity. 1989;2:543-552.
47. Wickham LA, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol. 2000;78:146-153.
48. Wickham LA, Rocha AM, Gao J, et al. Identification and hormonal control of sex steroid receptors in the eye. Adv Exp Med Biol. 1998;438:95-100.
49. Sullivan DA, Edwards JA, Wickham LA, et al. Identification and endocrine control of sex steroid binding sites in the lacrimal gland. Curr Eye Res. 1996;15:279-291.
50. Hewitt SC, Deroo BJ, Korach KS. Signal transduction: a new mediator for an old hormone? Science. 2005;307:1625-1630.
51. Richards SM, Liu M, Jensen RV, et al. Androgen regulation of gene expression in the mouse lacrimal gland. J Steroid Biochem Mol Biol. 2005;96:401-413.